Why it was recalled
Lack of sterility assurance
Product description
AMPICILLIN 8GM IN NS 400ML, antibiotic, used with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
Lot numbers, UPCs & expiration codes
Beyond Use Date: December 25-December 30, 2022
Where it was sold
Dispensed to Patients Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0275-2023
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Dec 27, 2022
- FDA report date
- Feb 22, 2023
- Quantity
- 14 bags
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Sentara Infusion Services
Original FDA data
Every field from FDA enforcement report D-0275-2023, exactly as published.
Show all FDA fields
- City
- Chesapeake
- State
- VA
- Status
- Terminated
- Country
- United States
- Event ID
- 91466
- Address
- 535 Independence Pkwy Ste 300
- Code information
- Beyond Use Date: December 25-December 30, 2022
- Postal code
- 23320-5176
- Report date
- Feb 22, 2023
- Product type
- Drugs
- Recall number
- D-0275-2023
- Classification
- Class II
- Recalling firm
- Sentara Infusion Services
- Product quantity
- 14 bags
- Termination date
- Feb 20, 2026
- Reason for recall
- Lack of sterility assurance
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- AMPICILLIN 8GM IN NS 400ML, antibiotic, used with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
- Distribution pattern
- Dispensed to Patients Nationwide.
- Recall initiation date
- Dec 27, 2022
- Initial firm notification
- Telephone
- Center classification date
- Feb 15, 2023